ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 1660

Role of Immune System Cells and Induction of Netosis-Mediated Cell Death in the Development of Atherosclerosis in Ankylosing Spondylitis

Yolanda Jiménez-Gómez1, Pilar Font-Ugalde1, Patricia Ruiz-Limon2, Maria Carmen Abalos-Aguilera2, M. Carmen Castro-Villegas3, Nuria Barbarroja1, Carlos Perez-Sanchez1, Ivan Arias de la Rosa2, Isabel Arias2, Rafaela Ortega-Castro1, Jerusalem Calvo-Gutierrez1, Chary Lopez-Pedrera1, Alejandro Escudero-Contreras2 and Eduardo Collantes-Estévez1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), atherosclerosis and inflammation, ROS

Session Information

Date: Monday, November 14, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Ankylosing Spondylitis (AS) is a chronic inflammatory disease associated with the development of atherosclerosis. Our aims were: 1) To evaluate the involvement of immune system cells and NETosis in the atherosclerosis process in AS patients. 2) To analyze in vitro the role of leukocyte subsets in the endothelial function.

Methods:  Thirty four AS patients and 34 healthy donors (HDs) were included in the study. Endothelial function was determined by the post occlusive hyperaemia test using Laser-Doppler. The expression of 84 genes related to atherosclerosis was determined in pooled RNA samples from peripheral blood mononuclear cells (PBMCs) of patients and HDs (n=3 each) by PCR array. Validation of several differentially expressed genes in PBMCs and the expression of various markers of oxidative stress and inflammation was quantified in leukocyte subsets. In neutrophils, NETosis markers and cell death by Sytox staining were also analyzed. Plasma DNA was quantified by fluorimetry. In vitro co-cultures of endothelial cells (HUVEC) with PBMCs or neutrophils from AS patients were performed.

Results: AS patients showed a prominent endothelial dysfunction, along with a significant alteration (fold change ≥ 2) in the expression of 50 genes related to atherosclerosis in PBMCs. Validation and expression studies showed that lymphocytes of AS patients exhibited an increase of inflammatory markers (STAT3, TNFα, IL1α, IL1β, IL6, IL23, IL2, ERAP1, IL10, IL5 mRNA), nitric oxide synthase (NOS) enzymes (NOS3 mRNA), and genes involved in adhesion (SELL, CDH5, THBS4 mRNA). In turn, monocytes displayed an augmented expression of inflammatory markers (STAT3, IFNγ, IL5, SPP1) and adhesion molecules (VCAM1, SELL), as well as a decrease in mRNA for IL6 and adhesive glycoprotein trombospondin 4 (THBS4). Neutrophils from AS patients showed a significant increase in NETosis and extruded plasma DNA levels, the latter associated with endothelial dysfunction present in AS. In addition, an increase of inflammatory markers (STAT3, TNFα, IL1β, IL1α, IL5 mRNA), adhesion molecules (ICAM1, SELL mRNA) and NOS3 mRNA was also found in this cell type. Oxidative status-related analyses demonstrated that leukocyte subsets from AS patients displayed an increase in oxidative stress and mitochondrial membrane potential, along with an alteration of TAC and NO at plasma levels. In vitro treatment of HUVECs with PBMCs or neutrophils from AS patients promoted an altered activity of the endothelial cells, which displayed altered expression of adhesion molecules, oxidative stress markers, cytokines and NOS enzymes, all of them associated to the pro-atherogenic profile of these patients.

Conclusion: 1) Leukocyte subsets from AS patients display an altered expression profile of key genes involved in the development of atherosclerosis. 2) NETosis is a cellular death mechanism occurring in AS, whose induction may act a key mediator of endothelial dysfunction in these patients. 3) That highly inflammatory PBMCs and neutrophils are responsible, at least partially, for the endothelial alteration displayed by AS patients. Funded by JA PI-0314-2012, SER


Disclosure: Y. Jiménez-Gómez, None; P. Font-Ugalde, None; P. Ruiz-Limon, None; M. C. Abalos-Aguilera, None; M. C. Castro-Villegas, None; N. Barbarroja, None; C. Perez-Sanchez, None; I. Arias de la Rosa, None; I. Arias, None; R. Ortega-Castro, None; J. Calvo-Gutierrez, None; C. Lopez-Pedrera, None; A. Escudero-Contreras, None; E. Collantes-Estévez, None.

To cite this abstract in AMA style:

Jiménez-Gómez Y, Font-Ugalde P, Ruiz-Limon P, Abalos-Aguilera MC, Castro-Villegas MC, Barbarroja N, Perez-Sanchez C, Arias de la Rosa I, Arias I, Ortega-Castro R, Calvo-Gutierrez J, Lopez-Pedrera C, Escudero-Contreras A, Collantes-Estévez E. Role of Immune System Cells and Induction of Netosis-Mediated Cell Death in the Development of Atherosclerosis in Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/role-of-immune-system-cells-and-induction-of-netosis-mediated-cell-death-in-the-development-of-atherosclerosis-in-ankylosing-spondylitis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-immune-system-cells-and-induction-of-netosis-mediated-cell-death-in-the-development-of-atherosclerosis-in-ankylosing-spondylitis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology